The trademark application Mabfilin was filed by Navigo Proteins GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on April 22, 2019, and it was registered by office on July 30, 2019 without any oppositions.
The application was filed in German (English was selected as the second language).
Goods And Services
The mark was filed in class 1 with Chemical, biological, analytical and/or chromatographic substances, active ingredients and/or compositions, in particular containing proteins, polypeptides, peptides or parts thereof, in particular proteins, peptides or polypeptides fused to antibodies or antibody fragments, for industrial and scientific applications, not for medical and veterinary use.
The mark was filed in class 5 with Diagnostic, therapeutic, analytical, biological, chemical and biochemical substances, active ingredients and/or compositions containing proteins, polypeptides and peptides, in particular proteins, peptides or polypeptides fused to antibodies or antibody fragments, for medical and veterinary applications.
The mark was filed in class 42 with following description of goods:
Scientific, technological and industrial services and research, in particular in the pharmaceutical, diagnostic, analytical or biochemical field
Services and research for identification, further development and use of biochemical, pharmaceutical, analytical or diagnostic products
Research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, genetic, biotechnological or biochemical methods.